New drug trial offers hope for painful skin condition
Disease control
Not yet recruiting
This study is testing a new drug called LAD191 for adults with moderate-to-severe hidradenitis suppurativa (HS), a painful skin condition. Researchers will compare different doses of LAD191 against a placebo and an existing drug (adalimumab) to see which is better at reducing the…
Phase: PHASE2 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC